Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

LS ARK Genomic Revolution Tracker ETP Securities XS2399368062

1.82
EUR
0.01
EUR
0.72%
21.11.2024
NAV

Nettoinventarwert (NAV)

1.91 USD 0.01 USD 0.43 %
Vortag 1.91 USD Datum 20.11.2024

LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX
LS ARK Genomic Revolution Tracker ETP Securities Chart

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 338.29%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Cardano ETP CH1102728750 144.49%
21Shares Ripple XRP ETP CH0454664043 87.77%
21Shares Fantom ETP CH1168929078 76.63%
21Shares Algorand ETP CH1146882316 72.00%
21Shares Injective Staking ETP CH1360612134 37.14%
21Shares Immutable ETP CH1360612142 20.47%
Name ISIN Performance
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Ripple XRP ETP CH0454664043 111.68%
21Shares Aave ETP CH1135202120 81.85%
21Shares Cardano ETP CH1102728750 71.55%
21Shares Solana staking ETP CH1114873776 43.44%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 312.24%
21Shares Bitcoin Core ETP CH1199067674 152.64%
21Shares Bitcoin ETP CH0454664001 149.42%
21Shares Binance BNB ETP CH0496454155 141.75%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 135.59%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’750.60%
21Shares Bitcoin Core ETP CH1199067674 466.71%
21Shares Bitcoin ETP CH0454664001 452.36%
21Shares Bitcoin Suisse ETP CH0496484640 349.61%
21Shares Bitwise Select 10 Large Cap Crypto Index ETP CH0475986318 333.94%

Fundamentaldaten

Valor
ISIN XS2399368062
Emittent Leverage Shares PLC
Aufgelegt in Ireland
Auflagedatum 10.12.2021
Kategorie Trading - Leveraged/Inverse Aktien
Währung USD
Volumen 465’178.89
Depotbank
Geschäftsjahresende
Berichtsstand 20.11.2024

Anlagepolitik

So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.

ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities

Performance 1 Jahr
-15.97
Performance 2 Jahre
-28.48
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -